Medicare Enrolled

Dr. Alec Koo, M.D.

Urology Physician · Torrance, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
23600 TELO AVE STE 220, Torrance, CA 90505
3106025005
In practice since 2006 (19 years)
NPI: 1740236066 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Koo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Koo

Dr. Alec Koo is an urology physician in Torrance, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Koo performed 5,786 Medicare services across 2,175 unique beneficiaries.

Between the years covered by Open Payments, Dr. Koo received a total of $203,891 from 61 pharmaceutical and/or device companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Koo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 17% volume in CA $203,891 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,786
Medicare services
Top 17% in CA for urology physician
2,175
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~305 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,980 $104 $600
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
1,161 $2 $9
Ultrasound of abdomen and pelvis blood flow
An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis.
673 $121 $190
Additional chronic care management time, 60 minutes
This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month.
456 $61 $340
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
303 $51 $300
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
245 $40 $240
Additional 30 minutes of principal care management
This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month.
209 $40 $270
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
127 $130 $780
Complex chronic care management, first 60 minutes
This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort.
123 $114 $640
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
114 $76 $440
Principal care management for high-risk disease, first 30 minutes
This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional.
105 $51 $170
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
85 $94 $560
Complete pelvic ultrasound
An imaging test using sound waves to create pictures of the organs and structures within the pelvis.
62 $87 $544
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
43 $217 $1,230
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
33 $55 $310
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
25 $287 $1,635
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
21 $10 $60
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
21 $21 $120
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$203,891
Total received (2018-2024)
Avg $29,127/year across 7 years
Top 3% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
580
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$143,408 (70.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$52,261 (25.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,222 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,221
2023
$11,677
2022
$30,448
2021
$24,639
2020
$27,133
2019
$51,714
2018
$54,059

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$2,758
ABBVIE INC.
$195
Sumitomo Pharma America, Inc.
$158
Tolmar, Inc.
$150
DePuy Synthes Sales Inc.
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$98
Astellas Pharma US Inc
$94
Bayer Healthcare Pharmaceuticals Inc.
$92
Verity Pharmaceuticals Inc.
$90
Ferring Pharmaceuticals Inc.
$80
Telix Pharmaceuticals
$51
Janssen Biotech, Inc.
$50
Laborie Medical Technologies Corp.
$48
PFIZER INC.
$47
PROGENICS PHARMACEUTICALS, INC.
$39
UROGEN PHARMA, INC.
$39
Dendreon Pharmaceuticals LLC
$33
Novartis Pharmaceuticals Corporation
$32
IMMUNITYBIO, INC.
$22
Cook Medical LLC
$18
Teleflex LLC
$14
Antares Pharma, Inc.
$14
Top 3 companies account for 73.7% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$38,822
Merck Sharp & Dohme Corporation
$38,036
Janssen Biotech, Inc.
$32,625
Merck Sharp & Dohme LLC
$25,706
Myovant Sciences Inc.
$15,480
AbbVie Inc.
$14,904
Bayer HealthCare Pharmaceuticals Inc.
$8,582
Dendreon Pharmaceuticals LLC
$7,548
Janssen Scientific Affairs, LLC
$6,191
ABBVIE INC.
$4,867
GENZYME CORPORATION
$2,791
AstraZeneca Pharmaceuticals LP
$1,810
SN Holdings, LLC
$1,573
Astellas Pharma US Inc
$974
PFIZER INC.
$502
Sumitomo Pharma America, Inc.
$347
Bayer Healthcare Pharmaceuticals Inc.
$346
Blue Earth Diagnostics Limited
$307
Tolmar, Inc.
$197
Verity Pharmaceuticals Inc.
$178
Progenics Pharmaceuticals, Inc.
$153
Myriad Genetic Laboratories, Inc.
$143
TOLMAR Pharmaceuticals, Inc.
$130
UroGPO LLC
$120
Ferring Pharmaceuticals Inc.
$107
DePuy Synthes Sales Inc.
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$98
UROGEN PHARMA, INC.
$96
Endo Pharmaceuticals Inc.
$85
Telix Pharmaceuticals
$82
Sun Pharmaceutical Industries Inc.
$75
Novartis Pharmaceuticals Corporation
$72
Teleflex LLC
$70
Antares Pharma, Inc.
$62
Foundation Medicine, Inc.
$61
PROCEPT BioRobotics Corporation
$49
Laborie Medical Technologies Corp.
$48
Acerus Pharmaceuticals Corporation
$46
Boston Scientific Corporation
$41
PROGENICS PHARMACEUTICALS, INC.
$39
Sagent Pharmaceuticals, Inc.
$37
Coloplast Corp
$34
BIOTISSUE HOLDINGS, INC.
$32
180 Medical, Inc.
$29
Otsuka America Pharmaceutical, Inc.
$23
IMMUNITYBIO, INC.
$22
ACCORD HEALTHCARE, INC.
$22
Alnylam Pharmaceuticals Inc.
$21
UROVANT SCIENCES INC
$21
Amgen Inc.
$20
Kowa Pharmaceuticals America, Inc.
$19
Cook Medical LLC
$18
Avadel Specialty Pharmaceuticals, LLC
$17
C. R. Bard, Inc. & Subsidiaries
$17
MEDIVATION FIELD SOLUTIONS LLC
$15
Smith+Nephew, Inc.
$15
SRS Medical Systems, Inc.
$14
Allergan Inc.
$14
Metuchen Pharmaceuticals
$14
Supernus Pharmaceuticals, Inc.
$14
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 53.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · AquaBeam Robotic System · Axumin · BOTOX · BRAC CDx · CAMCEVI · CONTINENCE CARE · CREON · ELIGARD · EMBOTRAP · ENTEREG · ERLEADA · Erleada · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · GEMTESA · GENERAL BPH · Glydo · ILLUCCIX · JATENZO · JELMYTO · JEVTANA · JYNARQUE · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ODOMZO · ORGOVYX · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · RESONANCE · SOLESTA · SPEEDICATH · STRAVIX · Seglentis · Solyx SIS System · Stendra · TLANDO · TOVIAZ · Trelstar · UROLIFT · UroCuff · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for urology physician in CA.

Looking for an urology physician in Torrance?
Compare urology physicians in the Torrance area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
314
Per 100K population
3.2
County median income
$87,760
Nearest hospital
DEL AMO HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Koo is a clinical cardiology specialist, with above-average Medicare volume (top 17% in CA), with speaking/promotional industry engagement in the top 3% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Koo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Koo performed 1,980 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Koo receive payments from pharmaceutical companies?
Yes. Dr. Koo received a total of $203,891 from 61 companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koo's costs compare to other urology physicians in Torrance?
Dr. Koo's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →